DK141051B - Analogifremgangsmåde til fremstilling af basisk substituerede theophyllin- eller theobrominderivater eller salte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af basisk substituerede theophyllin- eller theobrominderivater eller salte deraf.

Info

Publication number
DK141051B
DK141051B DK166677AA DK166677A DK141051B DK 141051 B DK141051 B DK 141051B DK 166677A A DK166677A A DK 166677AA DK 166677 A DK166677 A DK 166677A DK 141051 B DK141051 B DK 141051B
Authority
DK
Denmark
Prior art keywords
salts
preparation
analogous process
basic substituted
substituted theophylline
Prior art date
Application number
DK166677AA
Other languages
Danish (da)
English (en)
Other versions
DK166677A (sh
DK141051C (sh
Inventor
Heribert Offermanns
Karl Heinz Klingler
Klaus Thiemer
Fritz Stroman
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of DK166677A publication Critical patent/DK166677A/da
Publication of DK141051B publication Critical patent/DK141051B/da
Application granted granted Critical
Publication of DK141051C publication Critical patent/DK141051C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK166677AA 1976-04-15 1977-04-14 Analogifremgangsmåde til fremstilling af basisk substituerede theophyllin- eller theobrominderivater eller salte deraf. DK141051B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB15547/76A GB1527543A (en) 1976-04-15 1976-04-15 Basically substituted xanthine derivatives

Publications (3)

Publication Number Publication Date
DK166677A DK166677A (sh) 1977-10-16
DK141051B true DK141051B (da) 1979-12-31
DK141051C DK141051C (sh) 1980-06-16

Family

ID=10061083

Family Applications (1)

Application Number Title Priority Date Filing Date
DK166677AA DK141051B (da) 1976-04-15 1977-04-14 Analogifremgangsmåde til fremstilling af basisk substituerede theophyllin- eller theobrominderivater eller salte deraf.

Country Status (28)

Country Link
US (1) US4144340A (sh)
JP (1) JPS52128396A (sh)
AR (1) AR217426A1 (sh)
AT (1) AT350070B (sh)
AU (1) AU511983B2 (sh)
BE (1) BE853571A (sh)
CA (1) CA1078379A (sh)
CH (1) CH631454A5 (sh)
CS (1) CS196357B2 (sh)
DE (1) DE2716210A1 (sh)
DK (1) DK141051B (sh)
ES (2) ES457784A1 (sh)
FI (1) FI61900C (sh)
FR (1) FR2361395A1 (sh)
GB (1) GB1527543A (sh)
GR (1) GR63643B (sh)
IN (1) IN145872B (sh)
IT (1) IT1143568B (sh)
MX (1) MX5064E (sh)
NL (1) NL7704087A (sh)
NO (1) NO148291C (sh)
NZ (1) NZ183859A (sh)
PL (1) PL106083B1 (sh)
PT (1) PT66442B (sh)
RO (1) RO72835A (sh)
SE (1) SE431335B (sh)
SU (1) SU668604A3 (sh)
ZA (1) ZA772294B (sh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935062A1 (de) * 1978-09-06 1980-03-20 Degussa Substituierte aminoalkylguanidine, deren herstellung und arzneimittel
EP0022321A1 (en) * 1979-07-10 1981-01-14 Beecham Group Plc Benzene derivatives, their preparation and use in pharmaceutical compositions
DE2929596A1 (de) * 1979-07-21 1981-02-05 Hoechst Ag Verfahren zur herstellung von oxoalkyl-xanthinen
CH655658B (sh) * 1980-09-18 1986-05-15
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4406903A (en) * 1981-01-21 1983-09-27 John Wyeth And Brother Limited Xanthine derivatives useful as antidepressives
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT308139B (de) * 1970-07-27 1973-06-25 Degussa Verfahren zur Herstellung von neuen basisch substituierten Alkyltheophyllinen, ihren Isomeren und Säureadditionssalzen
AT311995B (de) * 1971-09-06 1973-12-10 Degussa Verfahren zur Herstellung von neuen basisch substituierten Alkyltheophyllinen
AT313916B (de) * 1971-10-28 1974-03-11 Degussa Verfahren zur Herstellung von neuen basisch substituierten Theophyllinen und deren Säureadditionssalzen
DE2308826C3 (de) * 1973-02-22 1980-03-27 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Phenoxyalkancarbonsäureester von Oxyalkyltheophyllinen, Verfahren zu ihrer Herstellung und Arzneimittel

Also Published As

Publication number Publication date
SU668604A3 (ru) 1979-06-15
AU2425677A (en) 1978-10-19
RO72835B (ro) 1983-07-30
AU511983B2 (en) 1980-09-18
ES457784A1 (es) 1978-03-01
SE431335B (sv) 1984-01-30
RO72835A (ro) 1983-08-03
ZA772294B (en) 1978-03-29
PL106083B1 (pl) 1979-11-30
IT1143568B (it) 1986-10-22
CS196357B2 (en) 1980-03-31
SE7704319L (sv) 1977-11-28
BE853571A (nl) 1977-10-14
CA1078379A (en) 1980-05-27
NO148291B (no) 1983-06-06
AR217426A1 (es) 1980-03-31
JPS52128396A (en) 1977-10-27
PT66442A (pt) 1977-05-01
NZ183859A (en) 1979-03-28
AT350070B (de) 1979-05-10
ES457783A1 (es) 1978-03-01
FI61900B (fi) 1982-06-30
NO148291C (no) 1983-09-14
FR2361395B1 (sh) 1981-02-13
FI61900C (fi) 1982-10-11
GB1527543A (en) 1978-10-04
GR63643B (en) 1979-11-28
FR2361395A1 (fr) 1978-03-10
ATA262677A (de) 1978-10-15
NO771301L (no) 1977-10-18
DK166677A (sh) 1977-10-16
NL7704087A (nl) 1977-10-18
DK141051C (sh) 1980-06-16
CH631454A5 (de) 1982-08-13
US4144340A (en) 1979-03-13
FI771187A (sh) 1977-10-16
MX5064E (es) 1983-03-09
IN145872B (sh) 1979-01-06
DE2716210A1 (de) 1977-11-03
PT66442B (pt) 1978-09-22

Similar Documents

Publication Publication Date Title
DK150512C (da) Analogifremgangsmaade til fremstilling af 3-quino-lincarboxylsyrederivater eller syreadditionssalte deraf
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK149111C (da) Analogifremgangsmaade til fremstilling af histidinderivater eller syreadditionssalte deraf
DK499778A (da) Fremgangsmaade til fremstilling af 9-(omegaheteroarylamino-alkylamino)-erythromyciner eller salte deraf
DK148260C (da) Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf
DK149609C (da) Analogifremgangsmaade til fremstilling af hydroxyamino-alkan- eller -alkenphosphonsyrederivater eller estere eller salte deraf
DK405477A (da) Fremgangsmaade til fremstilling af 5-alkoxyimidazo(1,2-a) quinolin-2-carboxylsyrer eller estere eller kationiske salte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK503080A (da) Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf
DK141051B (da) Analogifremgangsmåde til fremstilling af basisk substituerede theophyllin- eller theobrominderivater eller salte deraf.
DK155670C (da) Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf
DK146281C (da) Analogifremgangsmaade til fremstilling af 2-brom-6-fluor-n-2-imidazolidinyliden-benzamin eller syreadditionssalte heraf
DK27078A (da) Fremgangsmaade til fremstilling af imidazoquinoliner eller salte deraf
DK385777A (da) Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf
DK324979A (da) Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK149043C (da) Analogifremgangsmaade til fremstilling af 2-benzal- eller 2-benzyl-1-(aminoalkoxyimino)-cykloalkaner eller salte eller kvaternaere ammoniumderivater deraf
DK511878A (da) Fremgangsmaade til fremstilling af imidazobenzoazepiner eller salte deraf
DK58677A (da) Fremgangsmade til fremstilling af m-trifluormethylphenylpiperidinderivater eller additionssalte deraf
DK156066C (da) Analogifremgangsmaade til fremstilling af oxaloamino- eller hydroxyacetylaminobenzopyranderivater eller salte deraf med baser
DK223177A (da) Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf
DK147623C (da) Analogifremgangsmaade til fremstilling af azapurinderivater eller salte deraf
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK143403C (da) Analogifremgangsmaade til fremstilling af 8-(1h-tetrazol-5-yl)-11h-pyrido(2,1-b)quinazolin-11-oner eller salte deraf
DK147198C (da) Analogifremgangsmaade til fremstilling af 9-hydroxyethoxymethylguanin-monophosphat eller salte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed
B1 Patent granted (law 1993)
PBP Patent lapsed